 |
|
|
| |
Efficacy of once-weekly MK-8591 in SIV infected rhesus macaques
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy; June 8-10, 2016; Washington, DC
J.A. Grobler1, D. Nicoll-Griffith, M.-T. Lai, K. Fillgrove, A. Lindauer, M.L. Rizk, D.J. Hazuda
1Merck Research Labs, Antiviral Research, West Point, USA
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis......http://www.natap.org/2016/CROI/croi_14.htm
A Single Monotherapy Dose of MK-8591,a Novel NRTI, Suppresses HIV for Ten Days......http://www.natap.org/2016/CROI/croi_09.htm
|
| |
|
|
|
|
|
